|
CDER Proposes Supersizing Office of Generic Drugs, Mulls New Pharma Quality Office
CDER is looking to elevate the Office of Generic Drugs (OGD) into a “super” office, a move necessitated by the recent passage of the Generic Drug User Fee Amendments (GDUFA) and a heightened public focus on generic medicines, Center Director Janet Woodcock said Friday.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives